Staidson (beijing) Biopharmaceuticals Co., Ltd

This early-stage trial tested an experimental eye drop called STSP-0902 in 82 healthy volunteers to see if it is safe and how the body processes it. The study involved single and multiple doses, with some participants getting a placebo. The goal is to eventually treat neurotrophi…